[OTDev] [quixote-qcdb] Re: [BlueObelisk-discuss] Quixote project for computational chemistry and future possibilities for Blue Obelisk
Barry Hardy barry.hardy at douglasconnect.comTue Oct 26 20:05:50 CEST 2010
- Previous message: [OTDev] [quixote-qcdb] Re: [BlueObelisk-discuss] Quixote project for computational chemistry and future possibilities for Blue Obelisk
- Next message: [OTDev] [quixote-qcdb] Re: [BlueObelisk-discuss] Quixote project for computational chemistry and future possibilities for Blue Obelisk
- Messages sorted by: [ date ] [ thread ] [ subject ] [ author ]
Hi Peter (and new Quixote project coworkers): Good to hear from you Peter and to connect with you again, after a too long gap of some years :)! If only I still had our scribbled-on lunch napkins from 1995, all would be clear :)! I also think there is a great current opportunity to connect some of your work, CML, CDK, Blue Obelisk initiatives, Bioclipse etc. with the new OpenTox initiative and we have the possibilities to make "quite startling progress" in coming months. But we must also critically link OpenTox with pathways, systems biology and bioinformatics too, at least for supporting the growing integrated service and anaylsis needs of advancing the field of predictive toxicology. The questions we have to answer and whose answering we need to support go something along the lines of (http://opentox.org/home/documents/presentations/pathprot3presoct2010/view) : /What are the directions for Integrated Analysis in Predictive Toxicology that extend current strategies, methods and infrastructure to better include development and support of a combination of statistical, mechanistic and pathways based approaches to optimise progress in the quality and acceptance of alternative testing methods? How do we best leverage current knowledge and methods with regards to biological pathway analysis to design improved approaches to predictive toxicology that increase our ability to characterise the potential of chemicals to cause adverse human health effects and including an understanding of mode of action, mechanisms involved in the mode of action and the interaction of biological entities, pathways and networks in the perturbations introduced by the chemicals?/ /...and what variables need to be included in the interoperable service support design?/: Many including - Contexts for: A. Pathway Known B. Pathway Unknown and Rational Hypothesis is formed C.Pathway Unknown and no Rational Hypothesis currently formed and Variables for: - Most generally - any relevant interacting influencing variable in the complete environment of the planet - Chemicals, genes, proteins, modifications to any of previous, metabolites (and their interactions) - Species, Sex, Age, Diet, Organ(s) & Systems Interactions, Drugs, Genetics, Healthcare record, In vitro vs in vivo covariables - Organ, Organelle, Tissue, Cell -- Cell Combinations, Metabolism, Cell (Type, differentiation), Sub cellular compartments e.g., mitochondria, Concentration, Time, Dosage (amount, frequency), Route of Administration, Reversibility of Toxicity effects, System interactions (local, non-local) .....other factors:).... So we really have a Grand Interoperability Challenge almost demanding the benefits of a consensus-based Open & Public Standards/Ontology/Dictionary/Source/Data/Access approaches. (All the good stuff Peter has been driving for in cheminfo for many years!!) We ("OpenTox & Partners") are organising some workshop activity near Cambridge at EBI 15-17 November to discuss interoperability, data exchange standards, public ontologies, and a collaborative ontology development roadmap for the field of predictive toxicology. In addition to good science & engineering, there is also an increasingly strong business case driver, so we also have the collaboration and involvement of the EBI Industry Forum and Pistoia Alliance. We will also communicate outcomes aggressively with policy makers and program designers. Quo Vadis R&D progress and success in such scientific challenges without community, flexible infrastructure and interoperability? Participation in the workshop at EBI involves no registration fee but there are costs and places are limited - please contact me if you have an interest in contributing to what should be a significant landmark event for this field's progress! Barry Am 25.10.2010 13:51, schrieb Peter Murray-Rust: > On Mon, Oct 25, 2010 at 11:47 AM, Egon Willighagen< > egon.willighagen at gmail.com> wrote: > >> Nina, >> >> On Mon, Oct 25, 2010 at 12:28 PM, Peter Murray-Rust<pm286 at cam.ac.uk> >> wrote: >>> On Mon, Oct 25, 2010 at 10:33 AM, Nina Jeliazkova< >> jeliazkova.nina at gmail.com> wrote: >>>> For gaussian files it should be feasible as well, does CDK reads >> gaussian files ? >>> JUMBO does and the transofrmation is designed to be lossless by using a >> dictionary structure. >> >> CDK has only a minimal Gaussian readers, that extracts 3D coordinates, >> and might actually do vibrations, but nothing much else. >> >> I think what we will want to do, is extend the CDK CMLReader to >> understand the CMLComp conventions... > > That's exactly the right way to go. A typical CMLComp document (from a log > file) might include modules such as init; optimisation, final coords, > Hessian, Frequencies, NMR calculations. > > >
- Previous message: [OTDev] [quixote-qcdb] Re: [BlueObelisk-discuss] Quixote project for computational chemistry and future possibilities for Blue Obelisk
- Next message: [OTDev] [quixote-qcdb] Re: [BlueObelisk-discuss] Quixote project for computational chemistry and future possibilities for Blue Obelisk
- Messages sorted by: [ date ] [ thread ] [ subject ] [ author ]
More information about the Development mailing list